abstract |
Abstract The present invention relates to tetracyclodipyrano-coumarin compounds of general formula (I), wherein the substituents are defined herein. These compounds exihibit dual biological activities of anti human immunodeficiency virus type I (HIV-1) infection and anti Mycobacterium Tuberculosis (TB) infection. O R, R, Rs 0 0 x |C 391248 1 (GHMatlersPW480AU.1 |